Birchview Capital as of June 30, 2017
Portfolio Holdings for Birchview Capital
Birchview Capital holds 41 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 53.2 | $101M | 775k | 129.87 | |
| Accelr8 Technology | 31.6 | $60M | 2.2M | 27.35 | |
| Vermillion | 2.2 | $4.2M | 2.3M | 1.84 | |
| EQT Corporation (EQT) | 1.3 | $2.5M | 42k | 58.58 | |
| Biolase Technology | 0.7 | $1.2M | 1.3M | 0.97 | |
| Encana Corp | 0.6 | $1.2M | 132k | 8.80 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $1.2M | 25k | 45.99 | |
| Oxford Immunotec Global | 0.6 | $1.1M | 67k | 16.82 | |
| Vanda Pharmaceuticals (VNDA) | 0.6 | $1.1M | 68k | 16.29 | |
| Corcept Therapeutics Incorporated (CORT) | 0.6 | $1.1M | 95k | 11.80 | |
| Quidel Corporation | 0.6 | $1.1M | 39k | 27.15 | |
| Contrafect | 0.6 | $1.1M | 725k | 1.45 | |
| Yield10 Bioscience | 0.6 | $1.1M | 226k | 4.64 | |
| NxStage Medical | 0.5 | $857k | 34k | 25.06 | |
| Wright Medical | 0.4 | $825k | 30k | 27.50 | |
| Veracyte (VCYT) | 0.4 | $823k | 99k | 8.33 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.4 | $781k | 20k | 39.05 | |
| Masimo Corporation (MASI) | 0.4 | $729k | 8.0k | 91.12 | |
| Tesaro | 0.4 | $727k | 5.2k | 139.81 | |
| Paratek Pharmaceuticals | 0.4 | $727k | 30k | 24.11 | |
| Clovis Oncology | 0.3 | $655k | 7.0k | 93.57 | |
| Merck & Co (MRK) | 0.3 | $641k | 10k | 64.10 | |
| Sientra | 0.3 | $615k | 63k | 9.72 | |
| Quotient | 0.3 | $587k | 80k | 7.37 | |
| Sito Mobile (STTO) | 0.3 | $519k | 140k | 3.71 | |
| Pioneer Natural Resources | 0.2 | $479k | 3.0k | 159.67 | |
| Acceleron Pharma | 0.2 | $456k | 15k | 30.40 | |
| Celgene Corp right 12/31/2011 | 0.2 | $359k | 292k | 1.23 | |
| Biogen Idec (BIIB) | 0.1 | $271k | 1.0k | 271.00 | |
| Xencor (XNCR) | 0.1 | $260k | 12k | 21.14 | |
| Advaxis | 0.1 | $231k | 36k | 6.49 | |
| Genocea Biosciences | 0.1 | $204k | 39k | 5.23 | |
| Workhorse Group Inc ordinary shares | 0.1 | $185k | 50k | 3.70 | |
| Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.1 | $189k | 10k | 18.90 | |
| Aevi Genomic | 0.1 | $170k | 128k | 1.33 | |
| Opko Health (OPK) | 0.1 | $159k | 24k | 6.58 | |
| Roka Bioscience | 0.1 | $121k | 47k | 2.59 | |
| Pacific Biosciences of California (PACB) | 0.1 | $96k | 27k | 3.56 | |
| Oncomed Pharmaceuticals | 0.1 | $96k | 29k | 3.35 | |
| Merrimack Pharmaceuticals In | 0.0 | $55k | 44k | 1.25 | |
| Dicerna Pharmaceuticals | 0.0 | $63k | 20k | 3.15 |